the Prevalence of "Wearing-off" in Patients With Parkinson's Disease in Shanghai
NCT ID: NCT03792204
Last Updated: 2019-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1480 participants
OBSERVATIONAL
2017-09-01
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai
NCT04023201
The Profile of the Depression and it's Intervention Strategy in Patients With Parkinson's Disease in China
NCT03026595
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
NCT04453995
Shanghai Parkinson's Study
NCT00999388
Compensation Mechanisms in Parkinson's Disease
NCT02869945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD patients with wearing-off effect
people who have been clinically diagnosed with Parkinson's disease (PD) and have received anti PD therapy would be recruited into the study. The anti -PD treatment would not be changed in the population of the participants.
We would use the tool of 'Wearing-off 9 questionnaire' to determine the prevalence of Wearing-off phenomenon in Parkinson's patients in Shanghai
Wearing-off 9 questionnaire
The participants would receive appropriate anti-PD medical treatments according to the patients' need during the investigation.The anti -PD treatment would not be changed in the population of the participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wearing-off 9 questionnaire
The participants would receive appropriate anti-PD medical treatments according to the patients' need during the investigation.The anti -PD treatment would not be changed in the population of the participants.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have received stable anti-Parkinson's treatment before being recruited to the study.
Exclusion Criteria
* have not received anti Parkinsonian treatment.
* being combined with serious cognitive dysfunction or psychiatric symptoms
* unable to complete the investigations.
35 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhenguo Liu, Ph.D.
Role: STUDY_CHAIR
Xinhua hosipital affiliated to Shanghai Jiaotong university school of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xinhua hospital affiliated to Shanghai jiaotong university school of medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XH-18-011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.